Wide Ranks

CRMD

CorMedix Inc.

9.98

Top Statistics
Market Cap 605 M Forward PE 20.79 Revenue Growth 0.00 %
Current Ratio 3.96 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -11.03 Enterprise / Revenue 45.68 Price To Sales Trailing12 Months 49.38
Profitability
Profit Margins 0.00 % Operating Margins -28.69 %
Balance Sheet
Total Cash 46 M Total Cash Per Share 0.7590 Total Debt 556416
Total Debt To Equity 0.9480 Current Ratio 3.96 Book Value Per Share 1.01
All Measures
Short Ratio 451.00 % Message Board Id finmb_79611048 Fax 908 375 8272
Shares Short Prior Month 7 M Return On Equity -0.6504 City Berkeley Heights
Uuid 9c4131eb-b77e-37bc-b6ed-fb1c7402e601 Previous Close 9.78 First Trade Date Epoch Utc 1 B
Book Value 1.01 Beta 1.58 Total Debt 556416
Volume 727527 Price To Book 9.84 Last Split Date 1 B
Fifty Two Week Low 2.89 Total Cash Per Share 0.7590 Total Revenue 12 M
Shares Short Previous Month Date 1 B Target Median Price 17.50 Max Age 86400
Recommendation Mean 1.75 Sand P52 Week Change 0.3133 Operating Margins -28.69 %
Target Mean Price 16.25 Net Income To Common -46148452 Short Percent Of Float 0.1128
Implied Shares Outstanding 60 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 46 M
Next Fiscal Year End 1 B Revenue Per Share 0.2120 Held Percent Insiders 0.0097
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 9.78 Target Low Price 11.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 10.10 Open 9.89 Free Cashflow -39781652
State NJ Dividend Yield 0.00 % Return On Assets -0.3769
Time Zone Short Name EST Trailing Eps -0.8000 Day Low 9.61
Address1 300 Connell Drive Shares Outstanding 60 M Price Hint 2
Target High Price 19.00 Website https://www.cormedix.com 52 Week Change 2.07
Average Volume 1 M Forward Eps 0.4800 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 343.10 % Last Split Factor 1:5
Regular Market Day High 10.26 Is_sp_500 False Profit Margins 0.00 %
Debt To Equity 0.9480 Fifty Two Week High 13.85 Day High 10.26
Shares Short 6 M Regular Market Open 9.89 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 45.68 Revenue Growth 0.00 %
Shares Percent Shares Out 0.1127 Operating Cashflow -55745812 Currency USD
Time Zone Full Name America/New_York Market Cap 605 M Is_nasdaq_100 False
Zip 07922 Quote Type EQUITY Industry Biotechnology
Long Name CorMedix Inc. Regular Market Day Low 9.61 Held Percent Institutions 0.3190
Current Price 9.98 Address2 Suite 4200 Enterprise To Ebitda -11.03
Financial Currency USD Current Ratio 3.96 Gross Margins 83.57 %
Industry Disp Biotechnology Number Of Analyst Opinions 4 Country United States
Float Shares 60 M Two Hundred Day Average 6.11 Enterprise Value 560 M
Price To Sales Trailing12 Months 49.38 Forward PE 20.79 Regular Market Volume 727527
Ebitda -50766364 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States.

Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.

The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007.

CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.